DC
AMPE

Diametric Capital’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Diametric Capital’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-150
Closed -$76K – 199
2021
Q1 		$76K Buy
+150
New +$77.4K 0.06% 142

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Diametric Capital's AMPE Position: Q2 2021 in Review

Diametric Capital sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2021, closing a stake of 150 shares — an estimated $76K sold.

Diametric Capital first reported a position in AMPE in Q1 2021 and held it in 1 quarter. The position peaked at $76K in Q1 2021. 128 funds tracked by Wall St. Rank hold AMPE as of Q2 2021.

  • Diametric Capital reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2021 after selling out during the quarter.
  • Diametric Capital sold 150 Ampio Pharmaceuticals Inc. shares in Q2 2021, an estimated $76K.
  • Diametric Capital first reported a position in Ampio Pharmaceuticals Inc. in Q1 2021 and held it in 1 quarter.
  • Diametric Capital's Ampio Pharmaceuticals Inc. position peaked at $76K in Q1 2021.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2021.

Based on Diametric Capital's 13F filing for Q2 2021, filed 16 Aug 2021.